Platelets: The Tiny Cell Fragments That Can Save Your Life in Seconds

A platelet is not a complete cell in the conventional sense.

It has no nucleus. It cannot divide like an ordinary cell. It survives for only about a week before being removed and replaced. Each platelet begins as a tiny piece of cytoplasm released from an enormous parent cell called a megakaryocyte.

Yet the moment a blood vessel is damaged, these microscopic fragments become remarkably active.

They attach to the injured vessel wall, transform from smooth discs into spiky structures, release chemical signals, recruit nearby platelets, and link themselves together to form an emergency plug. The coagulation system then reinforces that plug with strands of fibrin, creating a stronger clot that limits blood loss while the damaged tissue begins repairing itself.

This response can begin within seconds.

There is, however, one important correction to the popular description:

Platelets have no nucleus and therefore no nuclear DNA, but they are not entirely without genetic material.

Platelets contain functioning mitochondria, and mitochondria carry their own mitochondrial DNA. They also inherit messenger RNA and protein-making machinery from their parent megakaryocytes, allowing them to produce selected proteins even without a nucleus.

The scientifically accurate story is therefore even more fascinating.

A platelet is a nucleus-free cellular fragment containing mitochondria, RNA, receptors, enzymes, signalling molecules, structural proteins, and storage granules. It cannot behave exactly like a conventional cell, but it is far from biologically passive.

It is a highly specialized emergency-response unit circulating silently through your bloodstream.

What Is a Platelet?

A platelet, also called a thrombocyte, is a small fragment of cytoplasm released from a much larger cell known as a megakaryocyte.

Human platelets are generally around two to four micrometres across, making them considerably smaller than red or white blood cells. When resting, they usually circulate as flattened, disc-shaped structures.

Their best-known function is hemostasis, the process through which the body prevents and stops bleeding.

Platelets help accomplish this by:

• Detecting blood-vessel damage
• Adhering to exposed tissue
• Activating and changing shape
• Releasing chemical signals
• Recruiting additional platelets
• Forming an initial platelet plug
• Supporting coagulation reactions
• Helping stabilize and contract the developing clot

They also contribute to inflammation, immune signalling, maintenance of blood-vessel integrity, and tissue repair.

Is a Platelet Really Not a Cell?

Platelets are frequently described as blood cells because they are counted alongside red and white blood cells and perform complex biological functions.

Structurally, however, mammalian platelets are more accurately described as anucleate cell fragments.

They do not begin as independent cells produced through ordinary cell division. Instead, they break away from the cytoplasm of megakaryocytes, carrying selected organelles, proteins, RNA molecules, receptors, membranes, and storage granules with them.

Because they have no nucleus, platelets lack the complete nuclear genome found in ordinary nucleated cells. They cannot perform normal nuclear transcription or divide through mitosis.

Nevertheless, platelets can:

• Generate energy
• Sense their environment
• Process external signals
• Rearrange their internal skeleton
• Secrete stored molecules
• Produce selected proteins from inherited RNA
• Interact with immune cells
• Release extracellular vesicles
• Undergo regulated forms of ageing and clearance

Research has even shown that anucleate platelets can form additional platelet-like bodies under experimental conditions, demonstrating that the absence of a nucleus does not make them inert.

Calling a platelet “just a fragment” is therefore technically correct but biologically incomplete.

It is a fragment equipped with an extraordinary amount of specialized machinery.

Do Platelets Have DNA?

Platelets do not contain a nucleus, so they do not carry nuclear DNA in the same way that white blood cells, skin cells, or liver cells do.

However, most platelets contain several mitochondria. These small organelles generate energy and carry their own circular mitochondrial genome.

Platelet mitochondrial DNA has been isolated, sequenced, and studied as a potential biological marker in cardiovascular, metabolic, neurological, and other diseases.

The accurate statement is therefore:

Platelets have no nucleus and no nuclear DNA, but they contain mitochondrial DNA.

This distinction matters because mitochondria contribute directly to platelet survival and activation.

Platelets typically contain only a small number of mitochondria, meaning damage to those organelles can have a substantial effect on their energy production, calcium regulation, oxidative signalling, lifespan, and ability to participate in clot formation.

Activated platelets can also release intact, functioning mitochondria into their surroundings. These extracellular mitochondria may influence inflammation and immune activity.

Platelets Also Contain RNA

For many years, the absence of a nucleus encouraged the assumption that platelets could not create new proteins.

Scientists now know that this is incorrect.

Platelets inherit messenger RNA and components of the protein-translation system from megakaryocytes. They can use those RNA instructions to produce selected proteins, and the pattern of protein production can change when the platelet becomes activated.

Platelets cannot create a completely new programme of nuclear gene transcription because they have no nucleus. However, they can process and translate RNA that was packaged into them during their formation.

Their RNA content is now studied for possible clues about:

• Cancer
• Cardiovascular disease
• Inflammation
• Infection
• Platelet production
• Medication response
• Megakaryocyte biology

Platelets are therefore an unusual biological compromise.

They have discarded the nucleus, making them smaller and more flexible, while retaining enough molecular machinery to respond dynamically during their short lives.

Where Do Platelets Come From?

Platelets originate mainly from megakaryocytes, exceptionally large cells associated with the bone marrow.

Unlike ordinary cells, megakaryocytes repeatedly copy their DNA without completing normal cell division. This produces a large, polyploid nucleus and an enormous cytoplasmic volume filled with the material needed to generate platelets.

A mature megakaryocyte extends long cytoplasmic projections toward blood vessels. Platelet-sized sections form along these extensions and are released into the circulation.

One megakaryocyte can contribute thousands of platelets during its productive life.

The process is highly organized.

The parent cell must distribute appropriate amounts of:

• Cell membrane
• Mitochondria
• RNA
• Cytoskeletal proteins
• Surface receptors
• Alpha granules
• Dense granules
• Enzymes
• Signalling molecules

Each released platelet must receive enough equipment to circulate, detect injury, and respond appropriately despite having no nucleus to replace missing components.

How Many Platelets Are in Your Blood?

A commonly used healthy reference range is approximately 150,000 to 450,000 platelets per microlitre of blood, although laboratory ranges and individual values vary.

An average adult has close to five litres of circulating blood.

Using those figures, a rough estimate suggests that an adult may have approximately 750 billion to 2.25 trillion circulating platelets at a given time.

The exact total varies with:

• Body size
• Blood volume
• Age
• Pregnancy
• Illness
• Medication
• Bone-marrow activity
• Platelet destruction and clearance

This means the original description actually understates the scale.

It is not merely millions of fragments circulating through the body. It is generally hundreds of billions or more, constantly passing through arteries, veins, and capillaries while remaining inactive unless they encounter the correct danger signals.

How Long Does a Platelet Live?

A typical human platelet remains in circulation for approximately seven to ten days.

After ageing, it is removed mainly through processes involving the liver and spleen. Meanwhile, megakaryocytes continually release replacements to maintain a relatively stable platelet population.

The body may produce and remove around 100 billion platelets per day to maintain this balance.

Platelet lifespan is influenced partly by internal survival and death pathways associated with mitochondria.

Because platelets cannot return to a nucleus to renew their entire molecular inventory, they gradually lose RNA, proteins, surface features, and functional capacity as they age. Their membranes also change in ways that help clearance systems identify them.

A platelet therefore lives fast.

It circulates for only several days, but during that time it may pass through the heart and blood vessels thousands of times, always prepared to respond to an injury.

What Happens When a Blood Vessel Is Injured?

A healthy blood vessel normally discourages platelets from sticking to its inner surface.

The intact endothelial lining releases substances that help maintain blood flow and suppress unnecessary platelet activation.

When the vessel wall is damaged, that protective surface is disrupted.

Underlying collagen and other components of the vessel’s supporting matrix become exposed. A large adhesive protein called von Willebrand factor, or VWF, helps capture circulating platelets at the damaged site, particularly where blood is moving rapidly.

The hemostatic response can be described in several overlapping stages:

1. Vessel constriction
2. Platelet adhesion
3. Platelet activation
4. Platelet aggregation
5. Coagulation and fibrin formation
6. Clot stabilization and retraction

These stages are closely connected rather than completely separate.

Stage One: The Vessel Constricts

Immediately after injury, the damaged blood vessel can narrow.

This vasoconstriction reduces blood flow through the injured region, helping limit blood loss while platelets and coagulation proteins begin forming a seal.

The effect alone is usually not enough to close a substantial injury, but it creates valuable time for the next defensive mechanisms.

Stage Two: Platelets Attach to the Damaged Surface

Platelets moving through healthy blood normally remain smooth and separate.

After vessel damage exposes collagen and associated adhesive proteins, platelet receptors begin interacting with the injured surface.

One especially important interaction occurs between:

• Von Willebrand factor attached near the damaged vessel wall
• The platelet GPIb-IX-V receptor complex

This interaction helps slow and capture platelets under blood-flow conditions that might otherwise sweep them past the injury.

Platelet receptors such as GPVI and integrin α2β1 also interact with exposed collagen, strengthening adhesion and initiating internal activation signals.

This first attachment can occur within seconds of vascular damage.

Stage Three: The Platelet Changes Shape

A resting platelet resembles a small, flattened disc.

Once activated, its internal cytoskeleton rapidly reorganizes. The platelet becomes more rounded and extends thin projections from its surface.

These projections increase the platelet’s surface area and help it contact:

• The damaged vessel wall
• Other platelets
• Fibrin strands
• Immune cells
• Coagulation proteins

Activation produces dramatic changes in shape, adhesion, aggregation, granule secretion, and clot contraction.

The transformation can be striking under a microscope.

A structure that previously appeared smooth and passive suddenly resembles a many-armed organism gripping its surroundings.

Yet this change occurs without a nucleus directing new gene transcription.

The response is executed through receptors, enzymes, calcium signals, cytoskeletal proteins, mitochondria, and molecular instructions already carried inside the platelet.

Stage Four: Activated Platelets Release Chemical Signals

Platelets contain several kinds of storage granules filled with biologically active molecules.

When a platelet becomes activated, these granules move toward the membrane and release their contents.

Dense granules contain substances involved in recruiting and activating additional platelets, including ADP and calcium-related components.

Alpha granules carry a broad range of proteins associated with adhesion, coagulation, inflammation, tissue repair, and interactions with other cells.

Activated platelets also generate thromboxane A2, a signalling molecule that strengthens recruitment and aggregation.

These signals amplify the response.

One activated platelet can help activate others. Those platelets release additional signals, bringing more fragments into the developing plug.

The process resembles an emergency alarm spreading through the local platelet population.

Stage Five: Platelets Grip One Another

Activation changes the behaviour of an important receptor called integrin αIIbβ3, also known as GPIIb/IIIa.

In resting platelets, the receptor has relatively low affinity for its bridging molecules.

After activation, it changes into a form capable of binding proteins such as fibrinogen and von Willebrand factor more effectively.

Fibrinogen can bind to activated receptors on two different platelets, effectively creating a molecular bridge between them.

More bridges form as additional platelets arrive.

This creates platelet aggregation—the process described informally as platelets gripping their neighbours.

The resulting platelet plug can rapidly cover the damaged area, but it is initially relatively fragile.

It needs reinforcement.

Stage Six: Fibrin Strengthens the Plug

At the same time that platelets are attaching and aggregating, coagulation proteins in the blood become activated through a chain of enzymatic reactions.

A key result is the production of thrombin.

Thrombin converts soluble fibrinogen into fibrin, which forms insoluble strands around and through the platelet mass.

These fibrin strands act like a reinforcing mesh, stabilizing the platelet plug and trapping additional blood components.

Activated platelets also expose membrane surfaces that help coagulation reactions proceed efficiently near the injury.

This localizes clot formation where it is needed rather than allowing uncontrolled coagulation throughout the circulation.

The finished clot is therefore not composed of platelets alone.

It includes:

• Aggregated platelets
• Fibrin
• Red blood cells
• White blood cells
• Plasma proteins
• Entrapped fluid and cellular material

The Clot Can Contract

After the clot forms, platelets use internal actin and myosin-related machinery to pull on the fibrin network.

This process, called clot retraction, helps compact the clot, draw the edges of the wound closer together, and strengthen the temporary seal.

The same cytoskeletal system that allowed the platelet to change shape now helps generate mechanical force.

A platelet is therefore not simply a piece of biological glue.

It is an active contractile component of the clot.

Platelets Help Begin Wound Repair

Stopping blood loss is only the first stage of healing.

Activated platelets release molecules that influence nearby cells and help coordinate inflammation and repair.

These signals can affect:

• Endothelial cells
• Immune cells
• Fibroblasts
• Smooth-muscle cells
• Tissue-repair pathways
• Formation of new blood vessels

Platelets therefore help create a temporary biological environment in which damaged tissue can begin recovering.

This does not mean that platelets alone heal wounds.

Wound repair is a complex process involving immune responses, extracellular matrix formation, cell migration, collagen production, blood-vessel growth, and tissue remodelling.

Platelets act as some of the earliest coordinators.

How Do Platelets Know Where the Injury Is?

Platelets do not consciously search for wounds.

They circulate continuously and respond when their receptors encounter molecular conditions normally hidden from flowing blood.

These signals include:

• Exposed collagen
• Immobilized von Willebrand factor
• Thrombin
• ADP
• Thromboxane A2
• Changes in blood-flow forces
• Molecules released from injured cells

The combination tells the platelet that the vessel lining has been disrupted.

Multiple signals are important because activating platelets unnecessarily would be dangerous.

A platelet response must be strong enough to stop bleeding but controlled enough to avoid blocking a healthy vessel.

Why Do Platelets Not Normally Stick Everywhere?

The bloodstream contains hundreds of billions of platelets, yet healthy vessels do not continuously fill with clots.

This is possible because intact endothelial cells actively discourage platelet adhesion and activation.

They produce and display substances that:

• Reduce platelet activation
• Break down platelet-activating molecules
• Promote vessel relaxation
• Maintain a smooth physical barrier
• Separate circulating platelets from collagen

Blood flow also helps disperse activating substances away from areas where no continuing injury exists.

Meanwhile, natural anticoagulant systems limit coagulation reactions, and fibrinolytic mechanisms eventually help break down clots when they are no longer required.

Hemostasis is therefore a controlled balance between bleeding and thrombosis.

When Platelets Become Dangerous

The same mechanisms that prevent fatal bleeding can become harmful when platelets activate inside an unbroken or diseased blood vessel.

A clot formed inside an artery can restrict or completely block blood flow.

Depending on its location, this may contribute to:

• Heart attack
• Ischemic stroke
• Limb ischemia
• Complications involving diseased arteries

Platelets are especially important in arterial clots because rapid blood flow and damaged atherosclerotic plaques create conditions that strongly promote platelet adhesion and aggregation.

This is why some patients at risk of arterial thrombosis receive antiplatelet medication.

These treatments reduce selected parts of platelet activation or aggregation. The therapeutic challenge is to lower the risk of dangerous clots without causing excessive bleeding.

What Happens When Platelet Numbers Are Too Low?

A low platelet count is called thrombocytopenia.

It can occur when:

• The bone marrow produces too few platelets
• Platelets are destroyed too quickly
• Platelets are consumed during illness
• Platelets become trapped or pooled
• Medications affect their production or survival
• Immune reactions target them

People with significant thrombocytopenia may experience:

• Easy bruising
• Pinpoint red or purple skin spots
• Prolonged bleeding
• Nosebleeds
• Gum bleeding
• Heavy menstrual bleeding
• Internal bleeding in severe cases

The risk depends not only on the platelet count but also on platelet function, the underlying condition, medication use, and whether the person is injured or undergoing surgery.

What Happens When Platelet Numbers Are Too High?

An abnormally high platelet count is known as thrombocytosis.

Some cases occur as a reaction to another condition, such as inflammation, infection, blood loss, or iron deficiency.

Others result from bone-marrow disorders that cause excessive platelet production.

A high count may increase the risk of abnormal clotting in some circumstances, although very high numbers can also be associated with bleeding because the platelets may not function normally.

The number alone does not tell the entire story.

Platelet quality and activity are just as important as quantity.

You Can Have Enough Platelets That Do Not Work Properly

Some people have a normal platelet count but impaired platelet function.

Functional problems can involve:

• Adhesion receptors
• Granule contents
• Signal pathways
• Fibrinogen binding
• Secretion
• Cytoskeletal movement
• Interactions with von Willebrand factor

Certain inherited disorders affect specific platelet components.

Medications can also reduce platelet function intentionally or unintentionally.

This explains why a standard blood count cannot diagnose every bleeding problem. Platelet-function testing may be needed when the number appears normal but bleeding remains unexplained.

Platelets Are Also Involved in Immunity

Platelets are traditionally introduced as clotting fragments, but their biological role is broader.

They interact with white blood cells and the blood-vessel lining. They can release inflammatory mediators, extracellular vesicles, RNA, proteins, and mitochondria. They also participate in responses associated with infection and tissue inflammation.

These immune activities can be protective, but excessive platelet activation can also contribute to harmful inflammation and thrombosis.

This overlap is especially important in severe infections, cardiovascular disease, inflammatory disorders, cancer, and neurological disease.

Modern platelet science increasingly views clotting, immunity, inflammation, and vascular biology as connected processes rather than completely separate systems.

Why Platelets Have No Nucleus

Losing the nucleus gives platelets several potential functional advantages.

It allows them to remain:

• Very small
• Flexible
• Numerous
• Easily distributed through narrow vessels
• Packed with specialized clotting machinery
• Unable to divide uncontrollably
• Replaceable through continuous production

Their small size and flexible structure help platelets move near vessel walls and enter rapidly developing clots.

The trade-off is limited lifespan and restricted ability to renew damaged components.

Instead of repairing platelets indefinitely, the body continually manufactures new ones.

This strategy resembles the use of disposable, highly specialized emergency equipment rather than long-lived general-purpose cells.

Are Platelets Alive?

This question depends on how “alive” is defined.

Platelets do not possess a nucleus or reproduce through ordinary cell division. However, they:

• Maintain metabolism
• Generate ATP
• Respond to stimuli
• Regulate calcium
• Change shape
• Move cellular components
• Synthesize selected proteins
• Communicate chemically
• Release organelles and vesicles
• Undergo ageing and regulated clearance

By many biological measures, platelets are living cellular structures.

They are not complete nucleated cells, but they are also not dead debris.

They occupy a fascinating position between a conventional cell and a specialized biological fragment.

Why the Shape Change Is So Important

A resting platelet’s disc shape is efficient for circulation.

After activation, its projections provide additional contact points and increase the surface available for interaction.

The shape change helps platelets:

• Spread across exposed tissue
• Form stable attachments
• Contact neighbouring platelets
• Concentrate clotting reactions
• Pull on fibrin fibres
• Seal irregularly shaped damage

Without cytoskeletal reorganization, platelets would be much less capable of building a durable plug.

The transformation is not decorative.

It is a mechanical adaptation essential to the emergency response.

Platelets Are Powerful Because They Cooperate

One platelet is microscopic and limited.

It cannot seal a substantial wound alone.

Its strength comes from rapid cooperation.

The first platelets that encounter exposed vessel material adhere and activate. They release signals that recruit additional platelets. Newly arriving platelets activate their own receptors, attach to the growing mass, and amplify the response further.

Fibrin then integrates the separate fragments into a mechanically connected structure.

The clot is therefore an example of biological collective action.

No individual platelet contains a central command system. The larger response emerges from local receptor interactions, chemical feedback, physical forces, and shared molecular rules.

Trillions of short-lived fragments circulate independently, yet they can assemble into an organized structure exactly where the vessel needs repair.

A More Scientifically Accurate Version of the Original Fact

The original statement can be refined as follows:

A platelet is not a complete nucleated cell. It is a tiny fragment released from a megakaryocyte, a giant cell associated with the bone marrow. Platelets have no nucleus or nuclear DNA, although they retain mitochondria, mitochondrial DNA, RNA, receptors, granules, and protein-making machinery. Within seconds of blood-vessel damage, they attach to the injured surface, transform from smooth discs into spiky structures, release chemical signals, recruit neighbouring platelets, and help build an emergency plug. Hundreds of billions of these fragments circulate silently through the bloodstream, ready to limit bleeding and help begin tissue repair.

This version preserves the wonder of the original while correcting the claim that platelets contain no DNA of any kind.

Final Thoughts

Platelets demonstrate that biological complexity does not always require a nucleus.

Each platelet is a temporary piece of a much larger cell. It contains no nuclear genome, cannot perform ordinary cell division, and survives for only about seven to ten days.

Yet during that brief existence, it can detect vascular damage, adhere under fast-flowing blood, reorganize its skeleton, extend gripping projections, release stored chemical signals, activate neighbouring platelets, support coagulation, pull on fibrin, influence immune responses, and help begin wound repair.

Its apparent simplicity is misleading.

A platelet carries an exceptionally concentrated collection of molecular tools designed for one urgent purpose: preserving the integrity of the circulation.

Most of the time, these fragments move through the bloodstream without attracting attention.

But when a vessel tears, they respond almost immediately.

One attaches.

Others follow.

The smooth fragments become spiky and adhesive. Molecular bridges connect them. Fibrin weaves through the growing mass. Blood loss slows, and the temporary seal holds while deeper repair begins.

You rarely notice this process.

It happens after cuts, scratches, internal vessel damage, and countless microscopic injuries that never become visible.

At every moment, hundreds of billions of nucleus-free fragments are circulating through your body, ready to sacrifice their short lives to keep your blood where it belongs.

Frequently Asked Questions

Is a platelet a complete cell?

A platelet is generally classified as an anucleate cell fragment rather than a complete nucleated cell. It is released from the cytoplasm of a megakaryocyte.

Do platelets have a nucleus?

No. Mature human platelets do not contain a nucleus.

Do platelets have DNA?

They do not contain nuclear DNA, but they contain mitochondria with mitochondrial DNA.

Do platelets contain RNA?

Yes. They inherit RNA from megakaryocytes and can use some of it to synthesize proteins.

Can platelets make proteins?

Yes. Although they cannot perform normal nuclear transcription, platelets retain translation machinery and can produce selected proteins from existing RNA.

Where are platelets produced?

They are produced mainly from megakaryocytes associated with the bone marrow.

How does a megakaryocyte make platelets?

A megakaryocyte extends cytoplasmic projections and releases small fragments containing membranes, receptors, organelles, RNA, proteins, and granules.

How many platelets are normally found in blood?

A commonly used reference range is approximately 150,000 to 450,000 platelets per microlitre, although ranges vary.

How many platelets are in the whole body?

A rough estimate based on standard blood volumes and count ranges suggests that an adult may carry hundreds of billions to more than two trillion circulating platelets.

How large is a platelet?

A typical platelet is only a few micrometres across.

How long does a platelet live?

Most circulate for approximately seven to ten days.

What removes old platelets?

Ageing platelets are cleared through processes involving the liver, spleen, and immune-related clearance systems.

How quickly do platelets react to injury?

Initial adhesion and activation can begin within seconds after blood-vessel damage.

Why do platelets change shape?

The shape change increases their surface area and helps them attach to damaged tissue, grip neighbouring platelets, and interact with fibrin.

What makes platelets stick to an injury?

Exposed collagen, von Willebrand factor, platelet receptors, and activation signals help capture and stabilize platelets at the damaged vessel wall.

What is von Willebrand factor?

Von Willebrand factor is a large adhesive protein that helps platelets attach to damaged blood vessels, particularly under rapid blood-flow conditions.

How do platelets stick to one another?

Activated platelet receptors bind bridging molecules such as fibrinogen and von Willebrand factor, connecting neighbouring platelets.

Are platelets the same as a blood clot?

No. Platelets form the initial plug, but a mature blood clot also contains fibrin and other blood components.

What is fibrin?

Fibrin is an insoluble protein network generated during coagulation that reinforces and stabilizes the platelet plug.

What is platelet activation?

Platelet activation is the rapid process involving receptor signalling, shape change, granule release, adhesion-receptor activation, and increased ability to aggregate.

What do platelet granules contain?

They contain molecules involved in platelet recruitment, adhesion, coagulation, inflammation, blood-vessel activity, and tissue repair.

Why do platelets not clot healthy vessels?

An intact vessel lining suppresses platelet activation, hides adhesive collagen, releases inhibitory molecules, and supports natural anticoagulant mechanisms.

Can platelets cause heart attacks or strokes?

Excessive platelet activation can contribute to clots that obstruct arteries, potentially causing heart attacks or ischemic strokes.

What is thrombocytopenia?

Thrombocytopenia is an abnormally low platelet count.

What is thrombocytosis?

Thrombocytosis is an abnormally high platelet count.

Can someone bleed with a normal platelet count?

Yes. A person may have enough platelets but have a disorder or medication effect that prevents them from functioning properly.

Do platelets help the immune system?

Yes. Platelets interact with immune and vascular cells and release molecules that influence inflammation, infection responses, and tissue repair.

Are platelets alive?

They are metabolically active cellular fragments. They lack nuclei and cannot divide normally, but they respond, signal, produce energy, synthesize selected proteins, and undergo regulated ageing.

What is the simplest accurate description of a platelet?

A platelet is a tiny, nucleus-free fragment of a megakaryocyte that circulates through the blood and rapidly helps seal damaged vessels.